Recombinant EGFR (Depatuxizumab Biosimilar) antibody (PE)
The Humanized Monoclonal anti-EGFR (Depatuxizumab Biosimilar) antibody is suitable to detect EGFR (Depatuxizumab Biosimilar) in samples from Human. It has been validated for FACS.
Catalog No. ABIN7867242
$569.23
Plus shipping costs $50.00
100 tests
Shipping to:
United States
Delivery in 2 to 4 Business Days
Quick Overview for Recombinant EGFR (Depatuxizumab Biosimilar) antibody (PE) (ABIN7867242)
Target
EGFR (Depatuxizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
PE
Application
Flow Cytometry (FACS)
-
-
Purpose
- PE-conjugated Anti-EGFR(depatuxizumab biosimilar) mAb
-
Isotype
- E239D, IgG1, M241L
-
-
-
-
Application Notes
- Flow Cyt 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2°C-8°C for 6 months
-
Expiry Date
- 6 months
-
-
- EGFR (Depatuxizumab Biosimilar)
-
Alternative Name
- depatuxizumab biosimilar
-
Target Type
- Biosimilar
-
Background
-
Synonyms: ERBB, ERBB1, HER1,ABT-806
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- P00533
Target
-
You are here:
